A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02
Stopped This study was voluntarily terminated due to a business decision not to proceed, and not due to any safety or efficacy issue
Conditions
Interventions
- OTHER: Safety and efficacy assessments
Sponsor
AVROBIO